@article{Palmateer_N-2021_37306,
title = {National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic},
author = {Palmateer, N. and Dickson, E. and Furrie, E. and Godber, I. and Goldberg, D. and Gousias, P. and Jarvis, L. and Mathie, L. and Mavin, S. and McMenamin, J. and McNeilly, T. and Murcia, P. and Murray, J. and Reid, G. and Robertson, C. and Templeton, K. and Von Wissman, B. and Wallace, L. and Waugh, C. and McAuley, A.},
month = {jul},
year = {2021},
abstract = {ObjectivesStudies that measure the prevalence of antibodies to SARS-CoV-2 (“seroprevalence”) are essential to understand population exposure to SARS-CoV-2 among symptomatic and asymptomatic individuals. We aimed to measure seroprevalence in the Scottish population over the course of the COVID-19 pandemic – from prior to the first recorded case in Scotland, through to the second pandemic wave.},
journal = {Public Health},
publisher = {Elsevier},
url = {https://doi.org/10.1016/j.puhe.2021.07.006},
}
